Recurrence-free survival is prolonged in high-grade serous ovarian cancer with high PD-L1 expression. - Lalos A; Lovrinovic M; Andersen K; Posabella A; Güth U; Stadlmann S; Delko T; Droeser RA; Singer G (BMC cancer, 2026)